Clinical trials
Phase 2/3 trials in the United Arab Emirates
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2022 | 5 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| Cellcolabs Clinical SPV Limited | 1 |
| Fakih IVF Fertility Center | 1 |
| Mohammed Bin Rashid University of Medicine and Health Sciences | 1 |
| Napo Pharmaceuticals, Inc. | 1 |
| Resverlogix Corp | 1 |
| Sanofi | 1 |
| Sheikh Khalifa Medical City | 1 |
| Suzhou Abogen Biosciences Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 2 |
| Breast Neoplasms | 1 |
| Bronchiolitis | 1 |
| Colitis, Ulcerative | 1 |
| Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 1 |
| Crohn Disease | 1 |
| Dermatitis, Atopic | 1 |
| Epidermolysis Bullosa Simplex | 1 |
| Inflammatory Bowel Diseases | 1 |
| Post-Acute COVID-19 Syndrome | 1 |
Trials
Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.